These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7432367)

  • 1. Use of the mouse spot test to investigate the mutagenic potential of triclosan (Irgasan DP300).
    Russell LB; Montgomery CS
    Mutat Res; 1980 Sep; 79(1):7-12. PubMed ID: 7432367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mammalian spot test and its use for testing of mutagenic and carcinogenic potential: experience with the pesticide chlordimeform, its principal metabolites and the drug lisuride hydrogen maleate.
    Lang R
    Mutat Res; 1984 Mar; 135(3):219-24. PubMed ID: 6708963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supermutagenicity of ethylnitrosourea in the mouse spot test: comparisons with methylnitrosourea and ethylnitrosourethane.
    Russell LB; Montgomery CS
    Mutat Res; 1982 Feb; 92(1-2):193-204. PubMed ID: 7088002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irgasan-induced pigmentation in Serratia marcescens and Pseudomonas aeruginosa.
    Kranz RG; Lynch DL
    Microbios; 1979; 24(97-98):195-207. PubMed ID: 119134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The antibacterial effect of Irgasan DP 300, Taisoal and Taisalite against oral bacteria].
    Ohta K; Kato T; Naito Y
    Shikwa Gakuho; 1984 Jun; 84(6):975-9. PubMed ID: 6597975
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutagenicity studies with the mouse spot test.
    Gocke E; Wild D; Eckhardt K; King MT
    Mutat Res; 1983 Apr; 117(1-2):201-12. PubMed ID: 6835259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenicity testing of benomyl, methyl-2-benzimidazole carbamate, streptozotocin and N-methyl-N'-nitro-N-nitrosoguanidine in Salmonella typhimurium in vitro and in rodent host-mediated assays.
    Ficsor G; Bordas S; Stewart SJ
    Mutat Res; 1978 Aug; 51(2):151-64. PubMed ID: 151228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorination of Irgasan DP300 and formation of dioxins from its chlorinated derivatives.
    Kanetoshi A; Ogawa H; Katsura E; Kaneshima H
    J Chromatogr; 1987 Feb; 389(1):139-53. PubMed ID: 3571350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mutagenic effect of caprolactam in the spot test with (T x HT) F1 mouse embryos.
    Neuhäuser-Klaus A; Lehmacher W
    Mutat Res; 1989 Nov; 224(3):369-71. PubMed ID: 2811928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irgasan DP300 in a deodorant.
    Hindson TC
    Contact Dermatitis; 1975 Oct; 1(5):328. PubMed ID: 1235286
    [No Abstract]   [Full Text] [Related]  

  • 11. Mutagenic activity of 2-amino-N6-hydroxyadenine in the mouse spot test.
    Neuhäuser-Klaus A
    Mutat Res; 1991 Aug; 253(1):109-14. PubMed ID: 1714539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial spectrum of triclosan, a broad-spectrum antimicrobial agent for topical application. II. Comparison with some other antimicrobial agents.
    Regös J; Zak O; Solf R; Vischer WA; Weirich EG
    Dermatologica; 1979; 158(1):72-9. PubMed ID: 761692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mouse spot test. Evaluation of its performance in identifying chemical mutagens and carcinogens.
    Styles JA; Penman MG
    Mutat Res; 1985 Nov; 154(3):183-204. PubMed ID: 3900714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of mutagenicity of diphenyl ether herbicides in Salmonella typhimurium YG1026 and YG1021.
    Oguri A; Karakama K; Arakawa N; Sugimura T; Wakabayashi K
    Mutat Res; 1995 Jan; 346(1):57-60. PubMed ID: 7530330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrolytic products from tryptophan and glutamic acid are positive in the mammalian spot test.
    Jensen NJ
    Cancer Lett; 1983 Sep; 20(2):241-4. PubMed ID: 6667463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent findings on the bactericidal power of 2,4,4-trichloro-2'-hydroxydiphenyl ether].
    Finzi G; Grimaldi G
    Arch Sci Med (Torino); 1980; 137(4):775-82. PubMed ID: 6788021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the remanent antibacterial effect of a 2% triclosan-detergent preparation on the skin.
    Bartzokas CA; Corkill JE; Makin T; Pinder DC
    J Hyg (Lond); 1983 Dec; 91(3):521-8. PubMed ID: 6363529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagenicity of 1,2-dibromo-3-chloropropane (DBCP) in the mouse spot test.
    Sasaki YF; Imanishi H; Watanabe M; Sekiguchi A; Moriya M; Shirasu Y; Tutikawa K
    Mutat Res; 1986 Jun; 174(2):145-7. PubMed ID: 3713732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of light emission from the bioluminescent bacterium Vibrio fischeri after exposure to triclosan and related hygiene care products.
    Martin EB; Mansfield LP; Smith A; Forsythe SJ
    Luminescence; 2001; 16(1):29-32. PubMed ID: 11180655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the mouse spot test in chemical mutagenesis: interpretation of past data and recommendations for future work.
    Russell LB; Selby PB; von Halle E; Sheridan W; Valcovic L
    Mutat Res; 1981 May; 86(3):355-79. PubMed ID: 7029265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.